Idiopathic Pulmonary Fibrosis (IPF)
Part of Respiratory Diseases
Companies in Idiopathic Pulmonary Fibrosis (IPF)
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
AstraZeneca
Cambridge, UK
AstraZeneca is a pharmaceutical company engaged in multi-year AI-powered drug discovery collaborations to identify validated targets in various disease areas.
...moreOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowCoreline Soft (코어라인소프트)
Seoul, South Korea
Coreline Soft (코어라인소프트) is an AI-based imaging solution company developing chest screening analysis products including lung cancer screening(LCS), COPD quantification, and coron...
...moreOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowPliant Therapeutics
South San Francisco, CA, United States
Pliant Therapeutics is a company developing treatments for fibrotic diseases.
Only accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join now
Insilico Medicine
New Territories, Massachusetts, Hong Kong
Global clinical-stage biotechnology company powered by generative AI focused on drug discovery.
Only accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join now